On the ninth anniversary of the Food and Drug Administration (FDA)’s draft “information sheet” regarding informed consent, an expansive 66-page final guidance paper has been issued. The publication demonstrates the first comprehensive revision by the FDA on this topic since 1998, affirming its persistent importance in the domain of human subjects research. The document, marked by considerable input from the Health Care Compliance Association (HCCA), puts forth a consolidated, refreshed exploration into the informed consent process. According to reports, the paper does not delve into the 2018 Common Rule.
Informed consent, a pivotal segment in any clinical research, remains critical in ensuring the ethical treatment of human subjects participating in trials. Through informed consent, subjects gain knowledge about the study’s potential risks, benefits, and their respective rights, thereby enabling them to make voluntary decisions about their involvement. The latest FDA guidelines reinforce the necessity of this process, delivering a nuanced perspective and in-depth instructions to researchers for implementing effective informed consent procedures.
Whilst the agency has addressed the topic sporadically over the years, the latest update indicates a notable remixing and consolidation of the existing guidelines. It reflects not only on previous guidance documents but also on current issues pertinent to clinical trials and human subject research. This indicates the agency’s commitment to keeping up with changing landscapes in the field of scientific investigation.
However, it should be noted that the newly issued guidance does not touch upon the revised Common Rule of 2018. The update to the federal policy for protection of human subjects, which revised and expanded the existing regulations with newer elements, has been left unaddressed. This twenty-first-century update to the biomedical research regulation seems conspicuously absent in an otherwise extensive document about informed consent.
To conclude, the new FDA guidance offers valuable insights and directions to researchers and institutions involved in human subject research, bolstering the process of informed consent towards ensuring more ethical conduct. Its omission of the 2018 Common Rule, however, leaves room for future discourse and deliberation within the research community.